Report Detail
Global Drug Discovery Preclinical CRO Market Growth (Status and Outlook) 2022-2028
- RnM4495272 |
- 15 November, 2022 |
- Global |
- 86 Pages |
- LPI(LP Information) |
- Medicine
The global market for Drug Discovery Preclinical CRO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug Discovery Preclinical CRO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug Discovery Preclinical CRO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug Discovery Preclinical CRO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug Discovery Preclinical CRO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug Discovery Preclinical CRO players cover Charles River, Wuxi Apptec, Eurofins Scientific, Pharmaron and Labcorp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug Discovery Preclinical CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug Discovery Preclinical CRO market, with both quantitative and qualitative data, to help readers understand how the Drug Discovery Preclinical CRO market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug Discovery Preclinical CRO market and forecasts the market size by Technology (HTS, FBDD and SBDD), by Application (Drug and Biologics.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by technology
HTS
FBDD
SBDD
Others
Segmentation by application
Drug
Biologics
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Charles River
Wuxi Apptec
Eurofins Scientific
Pharmaron
Labcorp
ChemPartner
Viva
Chapter Introduction
Chapter 1: Scope of Drug Discovery Preclinical CRO, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug Discovery Preclinical CRO market size and CAGR, Drug Discovery Preclinical CRO market size by region, by technology, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug Discovery Preclinical CRO revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug Discovery Preclinical CRO revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by technology, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug Discovery Preclinical CRO market size forecast by region, by country, by technology, and application
Chapter 13: Comprehensive company profiles of the leading players, including Charles River, Wuxi Apptec, Eurofins Scientific, Pharmaron, Labcorp, ChemPartner and Viva, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drug Discovery Preclinical CRO Market Size 2017-2028
- 2.1.2 Drug Discovery Preclinical CRO Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Drug Discovery Preclinical CRO Segment by Technology
- 2.2.1 HTS
- 2.2.2 FBDD
- 2.2.3 SBDD
- 2.2.4 Others
- 2.3 Drug Discovery Preclinical CRO Market Size by Technology
- 2.3.1 Drug Discovery Preclinical CRO Market Size CAGR by Technology (2017 VS 2022 VS 2028)
- 2.3.2 Global Drug Discovery Preclinical CRO Market Size Market Share by Technology (2017-2022)
- 2.4 Drug Discovery Preclinical CRO Segment by Application
- 2.4.1 Drug
- 2.4.2 Biologics
- 2.5 Drug Discovery Preclinical CRO Market Size by Application
- 2.5.1 Drug Discovery Preclinical CRO Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Drug Discovery Preclinical CRO Market Size Market Share by Application (2017-2022)
3 Drug Discovery Preclinical CRO Market Size by Player
- 3.1 Drug Discovery Preclinical CRO Market Size Market Share by Players
- 3.1.1 Global Drug Discovery Preclinical CRO Revenue by Players (2020-2022)
- 3.1.2 Global Drug Discovery Preclinical CRO Revenue Market Share by Players (2020-2022)
- 3.2 Global Drug Discovery Preclinical CRO Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Preclinical CRO by Regions
- 4.1 Drug Discovery Preclinical CRO Market Size by Regions (2017-2022)
- 4.2 Americas Drug Discovery Preclinical CRO Market Size Growth (2017-2022)
- 4.3 APAC Drug Discovery Preclinical CRO Market Size Growth (2017-2022)
- 4.4 Europe Drug Discovery Preclinical CRO Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Drug Discovery Preclinical CRO Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Drug Discovery Preclinical CRO Market Size by Country (2017-2022)
- 5.2 Americas Drug Discovery Preclinical CRO Market Size by Technology (2017-2022)
- 5.3 Americas Drug Discovery Preclinical CRO Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Drug Discovery Preclinical CRO Market Size by Region (2017-2022)
- 6.2 APAC Drug Discovery Preclinical CRO Market Size by Technology (2017-2022)
- 6.3 APAC Drug Discovery Preclinical CRO Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Drug Discovery Preclinical CRO by Country (2017-2022)
- 7.2 Europe Drug Discovery Preclinical CRO Market Size by Technology (2017-2022)
- 7.3 Europe Drug Discovery Preclinical CRO Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Drug Discovery Preclinical CRO by Region (2017-2022)
- 8.2 Middle East & Africa Drug Discovery Preclinical CRO Market Size by Technology (2017-2022)
- 8.3 Middle East & Africa Drug Discovery Preclinical CRO Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Drug Discovery Preclinical CRO Market Forecast
- 10.1 Global Drug Discovery Preclinical CRO Forecast by Regions (2023-2028)
- 10.1.1 Global Drug Discovery Preclinical CRO Forecast by Regions (2023-2028)
- 10.1.2 Americas Drug Discovery Preclinical CRO Forecast
- 10.1.3 APAC Drug Discovery Preclinical CRO Forecast
- 10.1.4 Europe Drug Discovery Preclinical CRO Forecast
- 10.1.5 Middle East & Africa Drug Discovery Preclinical CRO Forecast
- 10.2 Americas Drug Discovery Preclinical CRO Forecast by Country (2023-2028)
- 10.2.1 United States Drug Discovery Preclinical CRO Market Forecast
- 10.2.2 Canada Drug Discovery Preclinical CRO Market Forecast
- 10.2.3 Mexico Drug Discovery Preclinical CRO Market Forecast
- 10.2.4 Brazil Drug Discovery Preclinical CRO Market Forecast
- 10.3 APAC Drug Discovery Preclinical CRO Forecast by Region (2023-2028)
- 10.3.1 China Drug Discovery Preclinical CRO Market Forecast
- 10.3.2 Japan Drug Discovery Preclinical CRO Market Forecast
- 10.3.3 Korea Drug Discovery Preclinical CRO Market Forecast
- 10.3.4 Southeast Asia Drug Discovery Preclinical CRO Market Forecast
- 10.3.5 India Drug Discovery Preclinical CRO Market Forecast
- 10.3.6 Australia Drug Discovery Preclinical CRO Market Forecast
- 10.4 Europe Drug Discovery Preclinical CRO Forecast by Country (2023-2028)
- 10.4.1 Germany Drug Discovery Preclinical CRO Market Forecast
- 10.4.2 France Drug Discovery Preclinical CRO Market Forecast
- 10.4.3 UK Drug Discovery Preclinical CRO Market Forecast
- 10.4.4 Italy Drug Discovery Preclinical CRO Market Forecast
- 10.4.5 Russia Drug Discovery Preclinical CRO Market Forecast
- 10.5 Middle East & Africa Drug Discovery Preclinical CRO Forecast by Region (2023-2028)
- 10.5.1 Egypt Drug Discovery Preclinical CRO Market Forecast
- 10.5.2 South Africa Drug Discovery Preclinical CRO Market Forecast
- 10.5.3 Israel Drug Discovery Preclinical CRO Market Forecast
- 10.5.4 Turkey Drug Discovery Preclinical CRO Market Forecast
- 10.5.5 GCC Countries Drug Discovery Preclinical CRO Market Forecast
- 10.6 Global Drug Discovery Preclinical CRO Forecast by Technology (2023-2028)
- 10.7 Global Drug Discovery Preclinical CRO Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Charles River
- 11.1.1 Charles River Company Information
- 11.1.2 Charles River Drug Discovery Preclinical CRO Product Offered
- 11.1.3 Charles River Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Charles River Main Business Overview
- 11.1.5 Charles River Latest Developments
- 11.2 Wuxi Apptec
- 11.2.1 Wuxi Apptec Company Information
- 11.2.2 Wuxi Apptec Drug Discovery Preclinical CRO Product Offered
- 11.2.3 Wuxi Apptec Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Wuxi Apptec Main Business Overview
- 11.2.5 Wuxi Apptec Latest Developments
- 11.3 Eurofins Scientific
- 11.3.1 Eurofins Scientific Company Information
- 11.3.2 Eurofins Scientific Drug Discovery Preclinical CRO Product Offered
- 11.3.3 Eurofins Scientific Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Eurofins Scientific Main Business Overview
- 11.3.5 Eurofins Scientific Latest Developments
- 11.4 Pharmaron
- 11.4.1 Pharmaron Company Information
- 11.4.2 Pharmaron Drug Discovery Preclinical CRO Product Offered
- 11.4.3 Pharmaron Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Pharmaron Main Business Overview
- 11.4.5 Pharmaron Latest Developments
- 11.5 Labcorp
- 11.5.1 Labcorp Company Information
- 11.5.2 Labcorp Drug Discovery Preclinical CRO Product Offered
- 11.5.3 Labcorp Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Labcorp Main Business Overview
- 11.5.5 Labcorp Latest Developments
- 11.6 ChemPartner
- 11.6.1 ChemPartner Company Information
- 11.6.2 ChemPartner Drug Discovery Preclinical CRO Product Offered
- 11.6.3 ChemPartner Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 ChemPartner Main Business Overview
- 11.6.5 ChemPartner Latest Developments
- 11.7 Viva
- 11.7.1 Viva Company Information
- 11.7.2 Viva Drug Discovery Preclinical CRO Product Offered
- 11.7.3 Viva Drug Discovery Preclinical CRO Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Viva Main Business Overview
- 11.7.5 Viva Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Drug Discovery Preclinical CRO. Industry analysis & Market Report on Drug Discovery Preclinical CRO is a syndicated market report, published as Global Drug Discovery Preclinical CRO Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Drug Discovery Preclinical CRO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
